Abstract: The present disclosure provides a binding protein, e.g. an antibody, comprising at least one antigen binding domain which binds to necrotic enteritis B-like toxin (NetB), said antigen binding domain comprising a heavy chain variable region which comprises three complementarity determining regions (CDRs), preferably wherein said binding protein binds to NetB with a KD of 250 pM or less at pH 7.4. Said binding proteins can be used in the treatment or prevention of C. perfringens infection or Necrotic Enteritis. Nucleic acid molecules, expression vectors, host cells and compositions are also provided.
| # | Name | Date |
|---|---|---|
| 1 | 202417101514-STATEMENT OF UNDERTAKING (FORM 3) [20-12-2024(online)].pdf | 2024-12-20 |
| 3 | 202417101514-Sequence Listing in PDF [20-12-2024(online)].pdf | 2024-12-20 |
| 4 | 202417101514-REQUEST FOR EXAMINATION (FORM-18) [20-12-2024(online)].pdf | 2024-12-20 |
| 5 | 202417101514-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [20-12-2024(online)].pdf | 2024-12-20 |
| 6 | 202417101514-FORM 18 [20-12-2024(online)].pdf | 2024-12-20 |
| 7 | 202417101514-FORM 1 [20-12-2024(online)].pdf | 2024-12-20 |
| 8 | 202417101514-DRAWINGS [20-12-2024(online)].pdf | 2024-12-20 |
| 9 | 202417101514-DECLARATION OF INVENTORSHIP (FORM 5) [20-12-2024(online)].pdf | 2024-12-20 |
| 10 | 202417101514-COMPLETE SPECIFICATION [20-12-2024(online)].pdf | 2024-12-20 |
| 11 | 202417101514-RELEVANT DOCUMENTS [14-02-2025(online)].pdf | 2025-02-14 |
| 12 | 202417101514-FORM 13 [14-02-2025(online)].pdf | 2025-02-14 |
| 13 | 202417101514-FORM-26 [19-03-2025(online)].pdf | 2025-03-19 |
| 14 | 202417101514-Proof of Right [28-03-2025(online)].pdf | 2025-03-28 |
| 15 | 202417101514-FORM 3 [16-06-2025(online)].pdf | 2025-06-16 |
| 16 | 202417101514-Others-160725.pdf | 2025-07-21 |
| 17 | 202417101514-Correspondence-160725.pdf | 2025-07-21 |